Each Unit will consist of one common share of the Company ("Common Share") and one Common Share purchase warrant ("Warrant"). The Company will grant the Agent an option ("Agent's Option") to increase the size of the Offering by up to 15% in Units. Sales to investors in the United States will be subject to applicable United States securities laws and restrictions on securities purchased. The LIFE offering document ("Offering Document") related to the Offering can be accessed under the Company's profile at www.sedarplus.ca or on the Company's website at: www.theralase.com. For investor information on the Company, please feel to reach out Investor Inquiries - Theralase Technologies.